Indegene Ltd

Indegene Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indegene Ltd

₹ 548 -1.85%
30 Apr - close price
indegene.com BSE: 544172 NSE: INDGN
About

Incorporated in 1998, Indegene Ltd provides
solutions consisting of analytics, technology
and commercial, medical, regulatory and
safety services to life science and health
care organizations[1]

Key Points

Business Overview:[1]
IL is a digital-first healthcare and technology company. It helps bio pharmaceutical, emerging biotech and medical device companies to develop products and get them to market. Company brings together healthcare domain expertise, technology and an agile operating model to provide diverse solutions for patients and physicians.

Website BSE NSE
  • Market Cap ₹ 13,146 Cr.
  • Current Price ₹ 548
  • High / Low ₹ 737 / 469
  • Stock P/E 72.5
  • Book Value ₹ 78.7
  • Dividend Yield 0.00 %
  • ROCE 16.8 %
  • ROE 12.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Earnings include an other income of Rs.90.4 Cr.
  • Dividend payout has been low at 8.81% of profits over last 3 years
  • Working capital days have increased from 173 days to 293 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Part of BSE Allcap Nifty 500 BSE SmallCap BSE Healthcare BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
256 252 260 260 272 259 282 287 267
212 215 217 223 226 219 235 235 227
Operating Profit 44 38 43 37 46 40 46 52 40
OPM % 17% 15% 17% 14% 17% 15% 16% 18% 15%
9 12 6 12 23 14 22 22 35
Interest 2 2 2 2 2 2 2 2 2
Depreciation 10 9 8 6 8 7 6 6 7
Profit before tax 42 39 39 41 60 45 61 66 66
Tax % 32% 24% 26% 27% 19% 28% 27% 25% 18%
28 30 29 30 49 33 45 50 54
EPS in Rs 1.28 1.33 1.32 1.33 2.20 1.36 1.87 2.08 2.26
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
282 334 511 837 1,006 1,046 1,094
230 249 361 668 828 878 913
Operating Profit 53 86 150 169 178 168 180
OPM % 19% 26% 29% 20% 18% 16% 17%
12 -24 30 28 37 50 90
Interest 1 3 4 3 6 7 6
Depreciation 4 13 18 24 32 31 26
Profit before tax 59 46 159 170 177 181 238
Tax % 14% 30% 17% 22% 26% 24% 24%
51 32 132 133 130 138 181
EPS in Rs 324.22 202.30 843.58 755.26 5.87 6.20 7.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 26%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 9%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: 25%
3 Years: 11%
TTM: 46%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 14%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.31 0.30 0.30 0.40 44 44 48
Reserves 158 -3 254 650 751 909 1,840
106 362 23 44 51 38 27
57 72 96 156 191 228 234
Total Liabilities 322 431 373 850 1,038 1,220 2,150
8 31 41 72 78 56 53
CWIP 0 0 0 0 0 0 4
Investments 134 251 83 203 400 624 975
180 148 249 575 559 540 1,119
Total Assets 322 431 373 850 1,038 1,220 2,150

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
62 90 53 38 82 176 129
-70 -51 -34 -267 -51 -189 -825
15 -18 -37 245 -17 -16 717
Net Cash Flow 8 20 -18 16 14 -29 22

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65 65 125 152 145 132 137
Inventory Days
Days Payable
Cash Conversion Cycle 65 65 125 152 145 132 137
Working Capital Days 51 21 84 107 118 109 293
ROCE % 28% 49% 36% 24% 18% 17%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025
3.79% 4.82% 5.03% 5.24%
3.84% 3.17% 3.99% 4.96%
92.38% 92.01% 91.01% 89.80%
No. of Shareholders 2,03,5991,51,4401,53,7891,44,708

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls